LivePerson (LPSN) Form 3: 44,422 shares, 3,456 from notes
LivePerson (LPSN): Initial Form 3 filed by director Ryan L. Vardeman as of 10/14/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LivePerson (LPSN): Initial Form 3 filed by director Ryan L. Vardeman as of 10/14/2025. He reports 44,422 shares of common stock, held indirectly. He also reports indirect ownership of 0% Convertible Senior Notes due 2026 convertible into 3,456 shares at a conversion/exercise price of $1,128.39. The filing notes indirect ownership through Palogic entities and includes a standard disclaimer of beneficial ownership except to the extent of pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | 0% Convertible Senior Notes due 2026 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
- F2. The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
- F3. The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LivePerson (LPSN) disclose in this Form 3?
What is the event date for the LPSN Form 3?
What derivatives are reported in the LPSN Form 3?
Is the ownership direct or indirect in the LPSN Form 3?
Does the reporting person claim full beneficial ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.